retatrutide sign up 10mg — Triple Agonist GLP-1/GIP/Glucagon Research Peptide retatrutide clinical trial sign up

This approach is for people with a BMI above 50, severe diabetes or who'd like to lose 200 pounds or more

Taber DJ, Meadows HB, Pilch NA, Chavin KD, Baliga PK, Egede LE

For a 250-pound person, the difference between 14% weight loss and 28% weight loss is the difference between losing 35 pounds and losing 70 pounds

How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted

Do we ask patients to fail lifestyle interventions before they get treatment for hypertension

Please tell your provider if you are taking medications, especially for Types 1 or 2 diabetes